GlobeNewswire 12/22/2023 Oceana Finds China’s Fishing Fleet Swarms Galápagos, then Disappears from Sight
GlobeNewswire 12/19/2023 Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufacture...
GlobeNewswire 12/9/2023 Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 an...
GlobeNewswire 12/7/2023 Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at A...
GlobeNewswire 11/2/2023 Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies fo...
GlobeNewswire 11/1/2023 SweetWater Brewing Company Launches Special-Edition 420 IPA in Partnership With the Georgia Aquarium...
GlobeNewswire 10/30/2023 Galapagos concludes strategic evaluation and signs letter of intent to transfer Jyseleca® business t...
GlobeNewswire 9/19/2023 Galapagos appoints Simon Sturge to its Board of Directors
GlobeNewswire 8/28/2023 Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with...
GlobeNewswire 3/28/2022 Jyseleca® approved in Japan for ulcerative colitis
GlobeNewswire 3/24/2022 Correction: Galapagos publishes 2021 annual report and announces extraordinary and annual shareholde...
GlobeNewswire 3/24/2022 Galapagos publishes 2021 annual report and announces extraordinary and annual shareholders’ meetings
GlobeNewswire 3/18/2022 Galapagos increases share capital through subscription right exercises
GlobeNewswire 2/24/2022 Galapagos 2021 results set stage for future growth
GlobeNewswire 2/3/2022 Galapagos receives transparency notification from EcoR1 Capital
GlobeNewswire 2/2/2022 Galapagos provides further insights into the treatment of ulcerative colitis at the European Crohn’s...
GlobeNewswire 1/26/2022 Galapagos creates new subscription right plan
GlobeNewswire 1/26/2022 Galapagos appoints Paul Stoffels as Chief Executive Officer
GlobeNewswire 1/15/2022 Historic Decree Creates a New Marine Reserve – ‘Reserva Marina de Hermandad’– near the Galapagos Isl...
GlobeNewswire 1/13/2022 Galapagos creates new subscription right plan
GlobeNewswire 1/6/2022 Galapagos to present at 40th Annual J.P. Morgan Healthcare Conference
GlobeNewswire 12/30/2021 Dow Jones Celebrates 2021 Achievements
GlobeNewswire 12/3/2021 Galapagos increases share capital through subscription right exercises
GlobeNewswire 11/22/2021 Galapagos completes patient recruitment for MANGROVE Phase 2 trial with GLPG2737 in polycystic kidne...
GlobeNewswire 11/16/2021 WALTER P MOORE ANNOUNCES JESSALYN NELSON AS 2021 HORVILLEUR AWARD RECIPIENT